The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Developing a test to predict prostrate cancer risk

| | February 24, 2014

DNA testing can predict which men face the highest risk of deadly prostate cancer, scientists say. The team at the Institute of Cancer Research, in London, say men could soon be offered genetic screening in a similar way to breast cancer in women.

Prostate cancer is the commonest cancer in men in many countries, including the UK – where more than 40,000 people are diagnosed each year.

But not every patient has, or needs, invasive therapy that results in severe side-effects. Identifying which men will need treatment – those who are likely to develop the most aggressive and deadly form of the cancer – is a huge challenge.

Read the full, original story: DNA prostate test ‘will predict deadliest cancer risk’

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend